Table 5.
Quality of life measures showing Visual Function Questionairre-25 scores by group at six and 12 months.
Group | VFQ-25 score | St Dev | VFQ improvement | P value |
---|---|---|---|---|
ACZ to open-label ACZ | 91.95 | 8.75 | ||
91.64 | 6.03 | −0.31 | 0.78 | |
PLB to open-label ACZ | 86.05 | 12.27 | ||
88.64 | 10.7 | 2.59 | 0.01 | |
ACZ tapered off ACZ | 93.13 | 8.60 | ||
93.69 | 7.78 | 056 | 0.82 | |
PLB to no ACZ | 92.36 | 6.21 | ||
94.27 | 2.20 | 1.92 | 0.2 |
ACZ = acetazolamide, PLB = placebo, VFQ = Visual Function Questionairre